Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8958 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8936 |
High Similarity |
NPD1549 |
Phase 2 |
0.8841 |
High Similarity |
NPD1240 |
Approved |
0.8767 |
High Similarity |
NPD1512 |
Approved |
0.8723 |
High Similarity |
NPD1510 |
Phase 2 |
0.8714 |
High Similarity |
NPD1607 |
Approved |
0.863 |
High Similarity |
NPD6799 |
Approved |
0.863 |
High Similarity |
NPD1511 |
Approved |
0.8497 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8446 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8442 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8442 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8411 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8366 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8356 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8323 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8313 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8301 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8301 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8299 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8276 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8276 |
Intermediate Similarity |
NPD2796 |
Approved |
0.825 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8247 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8231 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8201 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8194 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.817 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8163 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8098 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8095 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8092 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8092 |
Intermediate Similarity |
NPD920 |
Approved |
0.8079 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8077 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8042 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8012 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7933 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7925 |
Intermediate Similarity |
NPD919 |
Approved |
0.7881 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7867 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7857 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7848 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7843 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7843 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7843 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7831 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7808 |
Intermediate Similarity |
NPD943 |
Approved |
0.7799 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7793 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7785 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7703 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7688 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7651 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7639 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7626 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7622 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7574 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.756 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7535 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7534 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD3226 |
Approved |
0.753 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2654 |
Approved |
0.75 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7485 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7434 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7434 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7432 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7419 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7415 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.741 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD1933 |
Approved |
0.74 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7386 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7376 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7357 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7349 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7329 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7325 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD411 |
Approved |
0.7314 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7301 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7301 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7294 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7273 |
Intermediate Similarity |
NPD17 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7232 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD1164 |
Approved |
0.72 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD1201 |
Approved |
0.717 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7089 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7067 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7041 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7029 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7029 |
Intermediate Similarity |
NPD74 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD7458 |
Discontinued |
0.697 |
Remote Similarity |
NPD37 |
Approved |
0.6964 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6957 |
Remote Similarity |
NPD9264 |
Approved |
0.6957 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD9263 |
Approved |
0.6957 |
Remote Similarity |
NPD9267 |
Approved |
0.6949 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6948 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD4966 |
Approved |
0.6946 |
Remote Similarity |
NPD4965 |
Approved |
0.6939 |
Remote Similarity |
NPD1091 |
Approved |
0.6932 |
Remote Similarity |
NPD8313 |
Approved |
0.6932 |
Remote Similarity |
NPD8312 |
Approved |
0.6928 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6915 |
Remote Similarity |
NPD7584 |
Approved |
0.6914 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6913 |
Remote Similarity |
NPD1876 |
Approved |
0.6908 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6892 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6887 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6883 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD5406 |
Approved |
0.6879 |
Remote Similarity |
NPD5404 |
Approved |
0.6879 |
Remote Similarity |
NPD5408 |
Approved |
0.6879 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD5405 |
Approved |
0.6875
|
Remote Similarity |
NPD6190 |
Approved |